object emerge tandem influenza ahnpdm virus saw signifies increase therapeutic prophylact use neuraminidas inhibitor nai mining impact highly transmits prior mani country stockpile develop plan antivirus drug base either treatment highrisk individual ndor prophylaxi contact howe date lack vivo model test efficacy influenzainfect expo household set method ferret model contact studi differ regimen prevent infect ferret ahnpdminfect index result among receive oseltamivir twice daily show better outcome benefit include delay time secondary lower weight loss higher active level h postinfect influence rate clinic symptom neither prevent reduce draw viral shed although improv infect anim concur prevent infect consist result reduce fail reduce tier warrant investing human 